Table 1 Clinical characteristics of the included normal controls and patients
From: The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
NC (n = 40) | PH (n = 163) | IHA (n = 28) | APA (n = 82) | |
|---|---|---|---|---|
Age (y) | 49.0 ± 11.5 | 48.6 ± 15.4 | 51.5 ± 10.9 | 46.0 ± 12.9 |
Sex (M/F) | 19 / 21 | 92 /71 | 18 / 10 | 37 / 45 |
BMI (kg/m2) | 25.0 ± 3.6 | 25.6 ± 4.0 | 25.2 ± 2.4 | 25.5 ± 8.9 |
SBP (mmHg) | 124.2 ± 9.3 | 145.4 ± 19.6A | 144.5 ± 13.4A | 152.0 ± 20.8AB |
DBP (mmHg) | 75.1 ± 9.5 | 89.0 ± 14.4A | 90.3 ± 11.9A | 94.7 ± 15.3AB |
Prevalence of hypokalemia (%) | – | – | 75.0 | 92.7c |
Serum potassium (mmol/L) | 4.0 ± 0.29 | 4.0 ± 0.25 | 3.3 ± 0.45AB | 3.2 ± 0.53AB |
Serum sodium (mmol/L) | 141.1 ± 1.9 | 141.0 ± 1.8 | 143.2 ± 2.3AB | 143.5 ± 3.7AB |
Urine potassium (mmol/24 h) | 36.7 ± 12.9 | 38.9 ± 15.6 | 57.5 ± 27.0AB | 58.2 ± 26.8AB |
Supine PRA (ng/ml.h) | 1.0 (0.55~1.9) | 1.4 (0.65~2.4) | 0.11 (0.03~0.26)AB | 0.14 (0.025~0.33)AB |
Supine PAC (ng/dl) | 11.2 ± 4.7 | 12.7 ± 3.8 | 15.0 ± 6.1Ab | 17.8 ± 5.5ABC |
ARR | 10.6 (5.4~17.1) | 8.9 (5.4~17.5) | 84.6 (64.6~556.2)AB | 117.5 (49.4~695.8)AB |